BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 21314493)

  • 1. Delivery of biologics to select organelles--the role of biologically active polymers.
    Dyer PD; Richardson SC
    Expert Opin Drug Deliv; 2011 Apr; 8(4):403-7. PubMed ID: 21314493
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 'Smart' delivery systems for biomolecular therapeutics.
    Stayton PS; El-Sayed ME; Murthy N; Bulmus V; Lackey C; Cheung C; Hoffman AS
    Orthod Craniofac Res; 2005 Aug; 8(3):219-25. PubMed ID: 16022724
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Polymeric vesicles: from drug carriers to nanoreactors and artificial organelles.
    Tanner P; Baumann P; Enea R; Onaca O; Palivan C; Meier W
    Acc Chem Res; 2011 Oct; 44(10):1039-49. PubMed ID: 21608994
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Functional polymers for targeted delivery of nucleic acid drugs.
    Mok H; Park TG
    Macromol Biosci; 2009 Aug; 9(8):731-43. PubMed ID: 19655399
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mucoadhesive polymeric platforms for controlled drug delivery.
    Andrews GP; Laverty TP; Jones DS
    Eur J Pharm Biopharm; 2009 Mar; 71(3):505-18. PubMed ID: 18984051
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Delivery of proteins and nucleic acids using a non-covalent peptide-based strategy.
    Deshayes S; Morris M; Heitz F; Divita G
    Adv Drug Deliv Rev; 2008 Mar; 60(4-5):537-47. PubMed ID: 18037526
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nucleic acid carriers based on precise polymer conjugates.
    Troiber C; Wagner E
    Bioconjug Chem; 2011 Sep; 22(9):1737-52. PubMed ID: 21749135
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nucleic-acid based gene therapeutics: delivery challenges and modular design of nonviral gene carriers and expression cassettes to overcome intracellular barriers for sustained targeted expression.
    Hsu CY; Uludağ H
    J Drug Target; 2012 May; 20(4):301-28. PubMed ID: 22303844
    [TBL] [Abstract][Full Text] [Related]  

  • 9. On the cellular processing of non-viral nanomedicines for nucleic acid delivery: mechanisms and methods.
    Vercauteren D; Rejman J; Martens TF; Demeester J; De Smedt SC; Braeckmans K
    J Control Release; 2012 Jul; 161(2):566-81. PubMed ID: 22613879
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bioadhesion technologies for the delivery of peptide and protein drugs to the gastrointestinal tract.
    Lehr CM
    Crit Rev Ther Drug Carrier Syst; 1994; 11(2-3):119-60. PubMed ID: 7600586
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of targeted delivery systems for nucleic acid drugs.
    Mahato RI; Takakura Y; Hashida M
    J Drug Target; 1997; 4(6):337-57. PubMed ID: 9239575
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of cationic carriers on the pharmacokinetics and tumor localization of nucleic acids after intravenous administration.
    de Wolf HK; Snel CJ; Verbaan FJ; Schiffelers RM; Hennink WE; Storm G
    Int J Pharm; 2007 Mar; 331(2):167-75. PubMed ID: 17134859
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Polymer-protein and polymer-drug conjugates in cancer therapy.
    Thanou M; Duncan R
    Curr Opin Investig Drugs; 2003 Jun; 4(6):701-9. PubMed ID: 12901229
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Polymer therapeutics: concepts and applications.
    Haag R; Kratz F
    Angew Chem Int Ed Engl; 2006 Feb; 45(8):1198-215. PubMed ID: 16444775
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Polymer conjugates: nanosized medicines for treating cancer.
    Vicent MJ; Duncan R
    Trends Biotechnol; 2006 Jan; 24(1):39-47. PubMed ID: 16307811
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthetic delivery systems for intravenous administration of nucleic acids.
    Schiffelers RM; de Wolf HK; van Rooy I; Storm G
    Nanomedicine (Lond); 2007 Apr; 2(2):169-81. PubMed ID: 17716119
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A GFP complementation system for monitoring and directing nanomaterial mediated protein delivery to human cellular organelles.
    Bale SS; Kwon SJ; Shah DA; Kane RS; Dordick JS
    Biotechnol Bioeng; 2010 Dec; 107(6):1040-7. PubMed ID: 20717973
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmaceutical approaches to colon targeted drug delivery systems.
    Chourasia MK; Jain SK
    J Pharm Pharm Sci; 2003; 6(1):33-66. PubMed ID: 12753729
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Polymers and nanoparticles: intelligent tools for intracellular targeting?
    Breunig M; Bauer S; Goepferich A
    Eur J Pharm Biopharm; 2008 Jan; 68(1):112-28. PubMed ID: 17804211
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Polymer conjugates as anticancer nanomedicines.
    Duncan R
    Nat Rev Cancer; 2006 Sep; 6(9):688-701. PubMed ID: 16900224
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.